Prostaglandin Oligomers: Potential Agents for the Protection Against The Effects of Oxygen Deprivation

  • George L. Nelson
Part of the Advances in Experimental Medicine and Biology book series (AEMB)


Prostaglandin derived oligomers are mixtures derived from the prostaglandin B1 (PGB1) family having the general formula (PGB1)n. In recent years, these materials have been derived exclusively from 15-dehydro-prosta-glandin B1 (15-dehydro-PGB1, 1a) and its derivatives. A number of unique in vitro and in vivo properties have been reported for these mixtures which appear to indicate an ability to prevent or restore damage at the cellular level resulting from oxygen deprivation. These properties suggest a potential application as a pharmaceutical agent or agents for protection against the harmful effects of stress, such as hypoxia and shock. The general lack of structural characterization of the initial mixtures has resulted in a serious block to the further development of these materials. Recently, structurally-defined dimer and trimer components, derived from a structurally modified 15-dehydro-PGB1 under mild reaction conditions, have been prepared. These structurally less complicated dimers and trimers retain the unique in vitro activities exhibited by the complex and structurally-undefined mixtures originally reported.


Size Exclusion Chromatography Chiral Center Mild Reaction Condition Oxygen Deprivation Crude Reaction Mixture 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    B. D. Polis, A. M. Grandizio and E. Polls, Some in vitro and in vivo effects of a new prostaglandin derivative (PGBx), Advances in Experi mental Medicine and Biology. 33:213 (1973).Google Scholar
  2. 2.
    B. D. Polis, S. Kwong, E. Polis and G. L. Nelson, PGBx; an oligomeric derivative of prostaglandin B1: Physical, chemical and spectral properties, Physiol. Chem. Physics. 12:1167 (1980).Google Scholar
  3. 3.
    B. D. Polis, S. Kwong, E. Polis, G. L. Nelson and H. W. Shumkler, Studies on PGBx; A polymeric derivative of prostaglandin Bl: Synthesis and purification of PGBx, Physiol. Chem. and Physics. 11:109 (1979).Google Scholar
  4. 4.
    B. D. Polis, E. Polis and S. Kwong, Protection and reactivation of oxidative phosphorylation in mitochondria by a stable free-radical prostaglandin polymer (PGBx), Proc. Natl. Acad. Sci. USA. 76:1598 (1979).PubMedCrossRefGoogle Scholar
  5. 5.
    D. K. Kreutter and T. M. Devlin, Inhibition of oxidative phosphorylation by an oligomer of prostaglandin B1, PGBx, Archives of Biochemistry and Biophysics. 221:216 (1983).PubMedCrossRefGoogle Scholar
  6. 6.
    H. W. Shmukler, M. G. Zwart, E. Soffer, W. Feely and E. Polis, Studies on the mechanism of mitochondrial protection by polymeric prostaglandin PGBx, Physiol. Chem. Physics. 14:471 (1982).Google Scholar
  7. 7.
    D. K. Kreuter and T. M. Devlin, Inhibition of mitochondrial F1Fo-ATPase by PGBx, a derivative of prostaglandin PGB1 Fed. Proc. 39:2151 (1980).Google Scholar
  8. 8.
    S. T. Ohnishi and T. M. Devlin, Calcium ionophore activity of a prostaglandin Bl derivative (PGBx), Biochemical and Biophysical Research Communications. 89:240 (1979).PubMedCrossRefGoogle Scholar
  9. 9.
    M. Kruger and J. Booyens, The effect of the prostaglandin derivative PGBx on calcium uptake and release by skeletal muscle sarcoplasmic reticulum, Sa Mediese Tydskrif Peel. 62:855 (1982).Google Scholar
  10. 10.
    C. N. Serhan, H. M. Korchak and G. Weissmann, PGBx, a prostaglandin derivative, mimics the action of the calcium ionophore A23187 on human neutrophils, J. Immunol. 80:2020 (1980).Google Scholar
  11. 11.
    D. K. Kreutter and T. M. Devlin, Modulation of mitochondrial Ca+2 retention by PGBx, an oligomeric derivative of prostaglandin B1. Fed. Proc. 40:1562 (1981).Google Scholar
  12. 12.
    H. W. Shmukler, Cation complex formation with PGBx, a prostaglandin oligomer, as measured by fluorescence quenching, Physiol. Chem. Physics. 80:558 (1981).Google Scholar
  13. 13.
    S. Narasimhulu and E. M. Brown, Interaction of PGBx and peroxides with cytochrome c and inhibition of lipid peroxidation, Arch. Biochem. Biophys. 243:461 (1985).PubMedCrossRefGoogle Scholar
  14. 14.
    R. C Franson, Medical College of Virginia, Richmond, VÂ. Personal communication.Google Scholar
  15. 15.
    E. T. Angelokos, R. I. Riley and B. D. Polis, Recovery of monkeys after myocardial infarction with ventricular fibrilation; Effects of PGBx, Physiol. Chem. Physics. 12:81 (1980).Google Scholar
  16. 16.
    G. Moss, T. Maglioccheti and R. Quarmby, Immediate restoration of central nervous system autonomic cardiopulmonary control: Survial of “lethal” cerebral hypoxia by treatment with prostaglandin Bx, Surg. Forum. 29:513 (1978).PubMedGoogle Scholar
  17. 17.
    R. J. Kolata and B. D. Polis, Facilitation of recovery from ischemic brain damage in rabbits by polymeric prostaglandin PGBx, a mitochondrial protective agent, Physiol. Chem. Physics. 13:545 (1981).Google Scholar
  18. 18.
    E. Polis and F. W. Cope, Polymeric prostaglandin PGBx and other prostaglandin polymers prolong survival of the heart of the hypoxic mouse, Aviat. Space Environ. Med., 54:420 (1983).PubMedGoogle Scholar
  19. 19.
    A. P. Walls, N. Himori and A. M. Burkman, Comparison of the effects of prostaglandin Bx (PGBx) and verapamil on changes in myocardial function that occur during ischemia, Proc. Fed. Am. Soc. Exp. Biol. Atlanta, GA. (1980).Google Scholar
  20. 20.
    S. T. Ohnishi and T. M. Devlin, Hahnemann University and Medical School, Philadelphia, PA. Personal communication.Google Scholar
  21. 21.
    G. L. Nelson and G. L. Verdine, The base promoted oligomerization of a 15-dehydro-PGBl analog: Structural insights into the complex oligomeric mixture termed PGBx, Tetrahedron Letters. 23:1967 (1982).CrossRefGoogle Scholar
  22. 22.
    G. L. Nelson and G. L. Verdine, The base promoted oligomerization of 15-dehydro-prostaglandin Bl: Dimer formation and structural implications for a complex mixture termed PGBx, Tetrahedron Letters. 23:991 (1983).CrossRefGoogle Scholar
  23. 23.
    G. L. Nelson, G. Verdine, J. Chmielewski and R. Marquis, The base promoted oligomerization of “C-16 Blocked” 15-dehydro-PGBl analogs Abstracts, 186th National Meeting of the American Chemical Society, Washington, D.C. (1983).Google Scholar
  24. 24.
    G. L. Nelson, G. Verdine, J. Chmielewski and R. Marquis, The base promoted oligomerization of a structurally modified 15-dehydro-PGBl: Retention of activity in less complicated oligomeric mixtures, Abstracts, 188th National Meeting of the American Chemical Society, Philadelphia, PA. (1984).Google Scholar
  25. 25.
    T. M. Devlin, R. Krupinski-Olsen, S. Uribe and G. L. Nelson, Effect of ollgomeric derivatives of prostaglandin B1 on oxidative phosphorylation and their Ca+2 ionophoretic activity, Biochem. Biophys. Res. Commun. 137:215 (1986).PubMedCrossRefGoogle Scholar
  26. 26.
    S. Uribe, S. T. Ohnishi, C. Israelite and T. M. Devlin, Calcium ionophoretic activity of chemically synthesized oligomeric derivatives of prostaglandin Bl, Biochim. Biophys. Acta. 924:87 (1987).PubMedCrossRefGoogle Scholar
  27. 27.
    S. Uribe, R. Villalobos-Molina and T. M. Devlin, Ca+2 ionophoretic activity of oligomers of prostaglandin Bl with isolated hepatocytes. Biochem. Biophys. Res. Commun. 143:1024 (1987).PubMedCrossRefGoogle Scholar
  28. 28.
    S. L. Cohan, D. K. J. E. von Lubitz and D. J. Redmond, Cerebral ischemia in gerbils: Reduction in mortality following treatment with oligo prostaglandin Bl, Abstracts, 17th Annual Meeting of the Society for Neuroscience. New Orleans, LA. (1987).Google Scholar
  29. 29.
    L. L. Widener, D. Bartos and L. Mela-Riker, Trimer of 15-dehydro-PGB1 improves recovery of mitochondrial function after renal ischemia. Abstracts, First International Shock Congress. Montreal, Canada. (1987).Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • George L. Nelson
    • 1
  1. 1.Department of ChemistrySaint Joseph’s UniversityPhiladelphiaUSA

Personalised recommendations